Applicant, as named in the Orange Book
Telix Innovations
Next listed expiry: Gozellix on 28 Jul 2035. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Gozellix NDA 219592 gallium ga-68 gozetotide | 28 Jul 2035 patent, carve-out possible |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.